PKI News and Press, PerkinElmer Inc. From 07/21/20

PerkinElmer (NYSE: PKI ) launches dry blood spot-based test for SARS-CoV-2 IgG using its GSP/DELFIA platform; enables processing of up to 5,000 samples per day. More news on: PerkinElmer, Inc., Healthcare stocks news, Read more ...

Fully automated kit detects human antibodies of immunoglobulin class IgG to help identify individuals with adaptive immune response PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a dry blood spot (DBS) base...

United First Partners chief Stephane Mardel says bullish preliminary results from life science toolmaker PerkinElmer ( PKI +3.5% ) is ratcheting up the pressure on Thermo Fisher Scientific ( TMO -0.4% ) to sweeten its €39/share (€10.4B) bid for diagnostic testmaker Qiagen (...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates growth in both reported revenue and organic revenue 1 of approximately 12% for the second quarter ended July 5, 2020. The strong revenue growth was driven b...

Thermo Fisher Scientific ( TMO +3.6% ) is up in early trade, albeit on below-average volume, after reporting that it expects Q2 sales above Wall Street views driven by strong deman d for COVID-19 tests, products and services that contributed more than $1.4B in revenue during the quarter. ...

WALTHAM, Mass. , June 18, 2020 /PRNewswire/ --  PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced a collaboration with the American Society of Hematology (ASH), the world's largest professional society of hematologists, t...

The U.S. Food and Drug Administration, together with the National Institutes of Health's National Cancer Institute, the Centers for Disease Control and Prevention, and the Biomedical Advanced Research and Development Authority, have been independently evaluating serology tests that detect the...

The presented market story on the Protein Crystallography Market announced via Market.us is a comprehensive analysis of the leading parameters that are likely to determine the growth of the protein crystallography market in the forthcoming decade. Further, the study dives in deep to examine th...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the (virtual) Jefferies Global Healthcare Conference on Thursday, June 4, 2020 at 9:00 a.m. ET. Jamey Mock, senior vice president and chief fina...

Reuters reports that diagnostics gear maker PerkinElmer ( PKI -0.9% ) is the target of a federal inquiry into possible Medicare fraud pertaining to "tens of thousands" of unnecessary genetic cancer tests. More news on: PerkinElmer, Inc., Healthcare stocks news, Stocks on the move, ...